Biosimilar Market, Application, Growth, Development and Forecast, 2022 – 2030


Biosimilar Market 2022-2030

A New Market Study, Titled “Biosimilar Market Upcoming Trends, Growth Drivers and Challenges” has been featured on fusionmarketresearch.


This global study of the Biosimilar Market offers an overview of the existing market trends, drivers, restrictions, and metrics and also offers a viewpoint for important segments. The report also tracks product and services demand growth forecasts for the market. There is also to the study approach a detailed segmental review. A regional study of the global Biosimilar industry is also carried out in North America, Latin America, Asia-Pacific, Europe, and the Near East & Africa. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.

Request Free Sample Report @

Fusion Market Research (FMR) has surveyed the Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

This report contains market size and forecasts of Biosimilar in global, including the following market information:
Global Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biosimilar revenues share in global market, 2021 (%)
Key companies Biosimilar sales in global market, 2017-2022 (Estimated)
Key companies Biosimilar sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AET BioTech
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Samsung Bioepsis
Zydus Cadila

Total Market by Segment:
Global Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar Market Segment Percentages, by Type, 2021 (%)
Oral Solution

Global Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

Ask Queries @

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Overall Market Size
2.1 Global Biosimilar Market Size: 2021 VS 2028
2.2 Global Biosimilar Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

7 Manufacturers & Brands Profiles
7.1 AET BioTech
7.1.1 AET BioTech Corporate Summary
7.1.2 AET BioTech Business Overview
7.1.3 AET BioTech Biosimilar Major Product Offerings
7.1.4 AET BioTech Biosimilar Revenue in Global Market (2017-2022)
7.1.5 AET BioTech Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biosimilar Major Product Offerings
7.2.4 Amgen Biosimilar Revenue in Global Market (2017-2022)
7.2.5 Amgen Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Biosimilar Major Product Offerings
7.3.4 Boehringer Ingelheim Biosimilar Revenue in Global Market (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Coherus Biosciences
7.4.1 Coherus Biosciences Corporate Summary
7.4.2 Coherus Biosciences Business Overview
7.4.3 Coherus Biosciences Biosimilar Major Product Offerings
7.4.4 Coherus Biosciences Biosimilar Revenue in Global Market (2017-2022)
7.4.5 Coherus Biosciences Key News
7.5 Fujifilm Kyowa Kirin Biologics
7.5.1 Fujifilm Kyowa Kirin Biologics Corporate Summary
7.5.2 Fujifilm Kyowa Kirin Biologics Business Overview
7.5.3 Fujifilm Kyowa Kirin Biologics Biosimilar Major Product Offerings
7.5.4 Fujifilm Kyowa Kirin Biologics Biosimilar Revenue in Global Market (2017-2022)
7.5.5 Fujifilm Kyowa Kirin Biologics Key News
7.6 LG Life Sciences/Mochida Pharmaceutical
7.6.1 LG Life Sciences/Mochida Pharmaceutical Corporate Summary
7.6.2 LG Life Sciences/Mochida Pharmaceutical Business Overview
7.6.3 LG Life Sciences/Mochida Pharmaceutical Biosimilar Major Product Offerings
7.6.4 LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue in Global Market (2017-2022)
7.6.5 LG Life Sciences/Mochida Pharmaceutical Key News
7.7 Momenta Pharmaceuticals
7.7.1 Momenta Pharmaceuticals Corporate Summary
7.7.2 Momenta Pharmaceuticals Business Overview
7.7.3 Momenta Pharmaceuticals Biosimilar Major Product Offerings
7.7.4 Momenta Pharmaceuticals Biosimilar Revenue in Global Market (2017-2022)
7.7.5 Momenta Pharmaceuticals Key News
7.8 Oncobiologics
7.8.1 Oncobiologics Corporate Summary
7.8.2 Oncobiologics Business Overview
7.8.3 Oncobiologics Biosimilar Major Product Offerings
7.8.4 Oncobiologics Biosimilar Revenue in Global Market (2017-2022)
7.8.5 Oncobiologics Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Biosimilar Major Product Offerings
7.9.4 Pfizer Biosimilar Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Samsung Bioepsis
7.10.1 Samsung Bioepsis Corporate Summary
7.10.2 Samsung Bioepsis Business Overview
7.10.3 Samsung Bioepsis Biosimilar Major Product Offerings
7.10.4 Samsung Bioepsis Biosimilar Revenue in Global Market (2017-2022)
7.10.5 Samsung Bioepsis Key News
7.11 Sandoz
7.11.1 Sandoz Corporate Summary
7.11.2 Sandoz Business Overview
7.11.3 Sandoz Biosimilar Major Product Offerings
7.11.4 Sandoz Biosimilar Revenue in Global Market (2017-2022)
7.11.5 Sandoz Key News
7.12 Zydus Cadila
7.12.1 Zydus Cadila Corporate Summary
7.12.2 Zydus Cadila Business Overview
7.12.3 Zydus Cadila Biosimilar Major Product Offerings
7.12.4 Zydus Cadila Biosimilar Revenue in Global Market (2017-2022)
7.12.5 Zydus Cadila Key News



Fusion Market Research is one of the largest collections of market research reports from numerous publishers. We have a team of industry specialists providing unbiased insights on reports to best meet the requirements of our clients. We offer a comprehensive collection of competitive market research reports from a number of global leaders across industry segments.


[email protected]

+ (210) 775-2636 (USA)
+ (91) 853 060 7487